Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahyd ro-naphtalen-1-ylamine for treating cancer

Details for Australian Patent Application No. 2006268657 (hide)

Owner ANCERIS

Inventors Telerman, Adam; Revah, Frederic; Balavoine, Fabrice; Amson, Robert; Tuynder, Marius

Agent Davies Collison Cave

Pub. Number AU-A-2006268657

PCT Pub. Number WO2007/006797

Priority 0507480 12.07.05 FR

Filing date 12 July 2006

Wipo publication date 18 January 2007

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/006797 Priority application(s): WO2007/006797

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268680-Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)

2006268656-Coated paper for sheet-fed offset printing